Acurx Pharmaceuticals
PUBLICATIONS
(Click on title to view publication)

ACX-362E
1.  Clostridium difficile DNA Polymerase IIIC: Basis for Activity of Antibacterial Compounds; Andrea Torti et al., Current Enzyme Inhibition, 2011,7,147-153
___________________________________

2.
 A Novel Agent Effective against Clostridium difficile Infection; Sofya Dvoskin, et al; Animicrob. Agents Chemother. 2012, 56 (3):1624.
DOI:10.1128/AAC.  06097-11; Published ahead of print 27 December 2011
______________________________________

3.  The Effects of Sub-Inhibitory Concentrations of a PolC-inhibitor on Clostridium difficile, E. van Eijk, 2016

General
1. Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of
America (SHEA)and the Infectious Diseases Society of America (IDSA); Stuart H. Cohen,et al; Infection Control and Hospital Epidemiology,
Vol. 31, No. 5  (May 2010), pp. 431-455; The University of Chicago Press on behalf of The Society for Healthcare Epidemiology of America
__________________________________

2. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of
America (IDSA) and Society for Healthcare Epidemiology of America (SHEA); L. Clifford McDonald, et al., Clinical Infectious Diseases 2018;
XX(00):1–48 (Downloaded from https://academic.oup.com/cid/advance-article abstract/doi/10.1093/cid/cix1085/4855916; on 23 February 2018
___________________________________
3. Burden of Clostridium difficile on the Healthcare System; Erik R. Dubberke and Margaret A. Olsen, Department of Medicine,
Washington University  School of Medicine, St Louis, Missouri; Clinical Infectious Diseases 2012;55(S2): S88–92
_______________________________

4. The Roles of Clostridium difficile and Norovirus Among Gastroenteritis-Associated Deaths in the United States, 1999–2007;
Aron J. Hall, et al., 216 CID 2012:55 (15 July)
___________________________________

5. Burden of Clostridium difficile Infection in the United States, Fernanda C. Lessa, M.D., M.P.H.,et al.; N Engl J Med, 372;9,
NEJM.ORG February 26, 2015
__________________________________

6. Clostridium difficile Infection; Wiep Klaas Smits, et al., NATURE REVIEWS, DISEASE PRIMERS VOLUME 2 | 2016 |